Scotia Capital Inc. Bio N Tech Se Transaction History
Scotia Capital Inc.
- $17.9 Billion
- Q4 2024
A detailed history of Scotia Capital Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Scotia Capital Inc. holds 175,224 shares of BNTX stock, worth $20.1 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
175,224
Previous 145,081
20.78%
Holding current value
$20.1 Million
Previous $17.2 Million
15.87%
% of portfolio
0.11%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$943 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$506 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$493 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$218 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$207 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...